HIV Vaccine Efficacy Trial Feasibility in the United States Vermund Vaccine Efficacy Trials for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Are Feasible in the United States: A Commentary on the HIVNET Vaccine Preparedness Study

Sorry, we couldn't extract an abstract for this paper.

Sorry, we couldn't extract any figures or tables for this paper.

Sorry, we couldn't extract any citations for this paper.

Sort by:

Showing 1-10 of 21 references

Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study.

Shots in the Dark: The Wayward Search for an AIDS Vaccine

Biological considerations in the development of a human immunodeficiency virus vaccine.

Human trials of HIV-1 vaccines.

Some important issues in the planning of phase III HIV vaccine efficacy trials.

The business of science and the science of business in the quest for an AIDS vaccine.

The implications of antigenic diversity for vaccine development.

Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.

HIV Vaccine Efficacy Trial Feasibility in the United States Vermund Vaccine Efficacy Trials for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Are Feasible in the United States: A Commentary on the HIVNET Vaccine Preparedness Study

Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study.

Shots in the Dark: The Wayward Search for an AIDS Vaccine

Biological considerations in the development of a human immunodeficiency virus vaccine.

Successful recruitment and conduct of the first HIV vaccine efficacy trial in North America and Europe

HIV vaccines

Human trials of HIV-1 vaccines.

Some important issues in the planning of phase III HIV vaccine efficacy trials.

The business of science and the science of business in the quest for an AIDS vaccine.

The implications of antigenic diversity for vaccine development.

Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.

HIV Vaccine Efficacy Trial Feasibility in the United States Vermund Vaccine Efficacy Trials for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Are Feasible in the United States: A Commentary on the HIVNET Vaccine Preparedness Study

Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study.

Shots in the Dark: The Wayward Search for an AIDS Vaccine

Biological considerations in the development of a human immunodeficiency virus vaccine.

Successful recruitment and conduct of the first HIV vaccine efficacy trial in North America and Europe

HIV vaccines

Human trials of HIV-1 vaccines.

Some important issues in the planning of phase III HIV vaccine efficacy trials.

The business of science and the science of business in the quest for an AIDS vaccine.

The implications of antigenic diversity for vaccine development.

Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.